✓ No loaded language, vague sourcing, or framing detected.
The Bridge program launched on July 1, 2026, enabling certain Medicare beneficiaries to obtain obesity medications for $50 per month. CVS and Walgreens have each reported filling around 100,000 prescriptions since the program's inception.
Our neutral summary
The Bridge program launched on July 1, 2026, enabling certain Medicare beneficiaries to obtain obesity medications for $50 per month. CVS and Walgreens have each reported filling around 100,000 prescriptions since the program's inception.
The reporting belongs to NPR — Top Stories; we don't reproduce it.
No note attached
on this article.
Drugstores say Medicare's $50 obesity drug program is catching on
Medicare's $50 obesity drug program sees early adoption